A Clinico-Pathological Study on Pleehodara w.s.r. to Splenomegaly and its Comparative Management with Sarapunkha Kshara and Sarapunkha Ghana Vati

Authors

  • Riksundar Nanda P.G. Scholar, P.G Dept of RNVV, GAC & H, Balangir, Odisha, India Author
  • Pradip Ku Panda Dean, SSCAS & RH, Sri Sri University, Cuttack, Odisha, India Author
  • Utkalini Nayak Reader, P.G Dept. of RNVV, GAC &H, Balangir, Odisha, India Author
  • Sushmirekha Panda P.G. Scholar, AIIMS, Bibinagar, Hyderabad. Author
  • Vinod Chandra Singh Lecturer, P.G. Dept. of RNVV,GAC & H, Balangir, Odisha, India Author

DOI:

https://doi.org/10.48165/

Keywords:

Udara roga, Pleehodara, Spleen, Splenomegaly

Abstract

Introduction- Udara rogas are classified into 8 types according to different Acharyas. Pleehodara is one among them.The main cause behind the development of Udara roga is  ‘Mandagni’. In Ayurveda Pleehodara may be correlated with Splenomegaly. Sarapunkha a  herbal drug mentioned in Ayurveda classics is effective in Pleehodara. So, a comparative single  blind study of Sarapunkha Kshara and Sarapunkha Ghana Vati are taken into consideration for  clinical trial for present study.  Aims: To study about the comparative clinical efficacy of Sarapunkha Kshara and Sarapunkha  Ghana Vati in the management of PleehodaraMaterial and Methods- This is a single-blind comparative clinical study with a pre-test and  post-test design. The patients were Randomly categorised into two groups.30 patients of Group A(15) and Group-B(15) patients were registered from OPD and IPD of Govt. Ayurvedic College  and Hospital, Balangir presented with Subjective parameters and Objective Parameters. After  diagnosis they were under trial with Ayurvedic formulations of Sarapunkha Kshara given  500mg twice daily after food in Group A and Sarapunkha Ghana Vati given 2tab (1 tab-500mg)  twice daily after food with luke warm water for a period of 30 days respectively. The subjective  and objective parameters were assessed in 10 days interval to interpret the result by statistical  evaluation. Observation and Results: It had been observed that the result of trial drug Group-A patients  was significant (<0.05) to reduce both subjective and objective Parameters after 30 days of  treatment as compare to Group-B patients. Conclusion: On comparison between two groups, Sarapunkha Kshara had shown more effect  than Sarapunkha Ghan Vati. No adverse effects were noticed during clinical trial in both groups

Downloads

Download data is not yet available.

References

Gupta A, Astanga Hridayam ‘Vidyotini Tika’ Nidana sthana Chapter 12/01 Chaukhamba Orientalia, Varanasi.2009.pp.348

Shastri AD, Susruta Samhita “Ayurveda tattva sandipika” Hindi Commentary purvardha, nidana sthana. chaukhambha bharati academy 2009.

P.J. Mehta’s Practical medicine by Nihar P. Mehta,SP Mehta, and SR joshi chapter 3.

Shastri S.N, Charaka Samhita Vidyotini tika Hindi vyakhya Vol-2 chikitsa sthana chapter-13. chaukhambha bharati academy,2008.

The Ayurvedic Pharmacopoeia of india part 2 volume 3 first edition 2010 appendix 6 page No. 246

Chaurasia B.D, Human Anatomy, Vol. 2, Sixth edition, CBS publishers and distributors Pvt. Ltd, New delhi, Chapter - 23

Textbook of pathology by Harsha Mohan seventh edition chapter 12.

Mishra B, Bhavaprakash of shri Bhava Mishra, Edited with the VIdyotini Hindi commentary, Chikitsa prakarana, Published by Chaukhamba Sanskrit bhaban, Varanasi.2007.

Srivastava, S, Sarangadharsamhita of Acharya Sarangadhar, edited by Jiwanprada Hindi Commentary, Published by Chaukhamba Orientalia, Varanasi.2006.

Bushan M, A critical review of Sarapunkha in management of Splenomegaly, Shalyatantra,Govt.Ayurveda College, Osmanabad, Maharastra.2005.

Downloads

Published

2022-07-31

How to Cite

Nanda, R., Panda, P.K., Nayak, U., Panda, S., & Singh, V.C. (2022). A Clinico-Pathological Study on Pleehodara w.s.r. to Splenomegaly and its Comparative Management with Sarapunkha Kshara and Sarapunkha Ghana Vati . International Research Journal of Ayurveda and Yoga, 5(7), 91–101. https://doi.org/10.48165/